CClinicalTrials.gg
CompletedNCT04718974C4L-YouthUpdated Feb 21, 2024Results posted

Call for Life Youth ART Adherence Study

An interventional study of mHealth call for life system/ tool using IVR ( interactive voice response) in ART Adherence, HIV-1-infection and mHealth, sponsored by Makerere University. Completed at 1 site in Uganda. Open to participants aged 15 Years to 24 Years. Per ClinicalTrials.gov, last updated 2024-02-21.

Sponsored by Makerere University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2020, registered Jan 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
206
Allocation
Randomized
Ages
15 Years to 24 Years
Sex
All
01

Study summary

Study purpose: To assess effect of mHealth Call for life Uganda tool (CFLU) on ART adherence among youth measured by interactive voice response to daily adherence calls mapped in the database and proportion with viral suppression of copies below 1000 copies/mL.

The intervention call for life Uganda (CFLU) uses IVR calls or text messages delivered via MOTECH™ based Connect for Life technology™. The calls are delivered in 4 languages (Luganda, English, Luo and Runyakitara) and the participant has to make a choice of the preferred language during registration to the system. The system offers adherence pill reminders, health message tips, visit appointment reminders and receipt of self-reported symptoms.

Read the detailed description

The intervention is mobile phone based IVR. However, the CLFU trial found that, it was observed that a good number of participants (50 of 256) at the urban site were not enrolled due to absence of a basic mobile phone, or had malfunctioning phone keyboards (for Poster Exhibition at the 20th International Conference on AIDS and STIs in Africa (ICASA 2019). Therefore, we shall provide a basic mobile phone to everyone in the study (SoC and intervention arm). To avoid stigma associated with a particular phone, we shall get 4 or more types of basic phones. Issues regarding simcard registration will be dealt with by the individuals.

Four study questionnaires will be administered at baseline and 6-monthly until the 12-month exit visit.

The questionnaires will capture:

  • Sociodemographic and medical history
  • Stigma scores
  • Knowledge assessment
  • Sexual behavior assessment
  • Knowledge of COVID-19 ( only at baseline) The data will be entered using REDCap. Blood for viral load will be collected at baseline and at the 6 and 12-month visit.

Intervention: mHealth CFLU tool The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda. The CFLU system follows the Health Insurance Portability and Accountability Act (HIPAA) Privacy and Security rules. While the Privacy rules deals with electronic Protected Health Information, the security rule covers administrative, physical and technical safeguards to ensure confidentiality, integrity and security of electronic protected health information. Data transaction between patient and system is encrypted when it comes to human subjects. The system is password protected, and interaction of system and patient is personalised with a secret code. The system interacts with the patient through a basic mobile phone via a keypad and with the health worker through a web-based interface. The system has options to either use interactive voice response or short message service and the user has to make a choice, get a secret pin code which ensures privacy to enduser.

Screening-Enrolment procedures:

All potential participants will be written on the screening log, and a screening form completed, reasons for screen failure will be documented on the screening log. Following successful screening, the participant will be referred to the Research Assistant (RA) to receive a thorough explanation of the study so and informed consent is obtained. The RA then administers the stigma questionnaire along with the sociodemographic and medical information, , HIV knowledge and sexual behaviour questionnaires. A client locater form will be completed which will help in physical contact tracing, and the participant will be registered on the enrolment log.

Randomisation will follow (see details of randomisation procedure below) thereafter and the result in the sealed envelope will dictate whether the patient will be registered onto the Call for Life System for the intervention or continue with standard of care as per Ministry of Health HIV Management guidelines.

Registration onto the CFLU system: Refer to Standard operating procedures on registration.

However, all patients will be registered onto the electronic and hard copy of the enrolment log and a next appointment date is given to them. Finally, the lab request forms are filled and the patient sent for a blood draw. The patient returns from the lab, receives their transport refund of UGX 20,000, with a basic mobile phone (only at baseline visit, to all participants) and is allowed to go home.

No intervention: Standard of care arm The Ministry of Health developed a minimum healthcare services package for PLHIV to standardize the programming, implementation and delivery of integrated HIV services in Uganda The standard of care arm is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV (Uganda. MoH, September 2014).

02

Conditions studied

  • ART Adherence
  • HIV-1-infection
  • mHealth

Keywords

  • Youth
  • Adherence
  • ART
  • mobile health
  • resource poor setting
03

In context

Lead sponsor

Makerere University is the lead sponsor of 143 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Youth living with HIV
  • Documented HIV test result
  • ART naïve or on ART since Jun 2019

Exclusion criteria

Exclusion Criteria:

  • Youth with Hearing loss,
  • Youth with severe illness likely to shorten life span,
  • Youth in boarding schools
  • Inability to use a basic mobile phone
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
206 participants (actual)

Study arms

  • Experimental
    intervention " Call for life- mHealth tool" with standard of care for PLHIV

    The system has options to either use interactive voice response or short message service and the user has to make a choice, get a secret pin code which ensures privacy to end user. The mHealth tool/system offers personalised pill reminder calls, health tip messages, clinic appointment reminders and remote symptom reporting

    Other: mHealth call for life system/ tool using IVR ( interactive voice response)

  • No intervention
    Standard of care "usual care"

    Standard • Care and support for people living with HIV, and the first line ART regimen is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV including the Adult Care and Treatment Package.

Interventions

  • OthermHealth call for life system/ tool using IVR ( interactive voice response)

    The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda

    Also known as: Call for life -mHealth tool

06

What researchers measure

Primary outcomes

  1. • Viral Load Suppression

    Viral load suppression as per Blood draws at 6 months for those on intervention and those on standard of care arm will be used to measure viral load at these time points

    Time frame: • Viral load suppression at 6 months

  2. • Viral Load Suppression

    Viral load suppression as per Blood draws at 12 months for those on intervention and those on standard of care arm will be used to measure viral load status at these time points

    Time frame: • Viral load suppression at 12 months

  3. Proportions Retained in Care

    Proportions of youth retained in care at 12 months for those on intervention in comparison to those on standard of care arm

    Time frame: 12 months

07

Results

Posted Feb 21, 2024

Participant flow

Recruitment started on 12th Aug 2020. Reccruitment was from three HIV/ART clinics in Kiryandongo District

Participant flow — Overall Study
MilestoneIntervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"
Started103103
Completed9177
Not completed1226
Withdrew: Death02
Withdrew: Lost to follow-up1020
Withdrew: Transferred out24

Outcome measures

Primary• Viral Load Suppression

Viral load suppression as per Blood draws at 6 months for those on intervention and those on standard of care arm will be used to measure viral load at these time points

Time frame:
• Viral load suppression at 6 months
Reported as:
Count of participants · Participants
• Viral Load Suppression
ParticipantsIntervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"
• Viral Load Suppression6146
Primary• Viral Load Suppression

Viral load suppression as per Blood draws at 12 months for those on intervention and those on standard of care arm will be used to measure viral load status at these time points

Time frame:
• Viral load suppression at 12 months
Reported as:
Count of participants · Participants
• Viral Load Suppression
ParticipantsIntervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"
• Viral Load Suppression6740
PrimaryProportions Retained in Care

Proportions of youth retained in care at 12 months for those on intervention in comparison to those on standard of care arm

Time frame:
12 months
Reported as:
Count of participants · Participants
Proportions Retained in Care
ParticipantsIntervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"
Proportions Retained in Care9177

Adverse events

Collected over Adverse event data were collected from participant randomization until exit. This period was 1year and 9 months.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIV0/103 (0%)1/103 (1%)0/103 (0%)
Standard of Care "Usual Care"2/103 (1.9%)2/103 (1.9%)0/103 (0%)
Most frequent serious events
Most frequent serious events
EventIntervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"
DeathInfections and infestations0/1032/103
Road traffic AccidentMusculoskeletal and connective tissue disorders1/1030/103

Baseline characteristics

Young people 15-24 years initiating or on ART since 2019.

Age, Continuous
Age, Continuous(years)Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"Total
Mean22.5 ± 1.922.2 ± 2.322.3 ± 2.1
Sex: Female, Male
Sex: Female, Male(Participants)Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"Total
Female8285167
Male211839
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"Total
Hispanic or Latino000
Not Hispanic or Latino000
Unknown or Not Reported103103206
Region of Enrollment
Region of Enrollment(Participants)Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"Total
Uganda103103206
Viral load detection at baseline
Viral load detection at baseline(Participants)Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIVStandard of Care "Usual Care"Total
Count of participants463278
08

Study locations

1 site
  • Kiryandongo
    Kiryandongo, 256, Uganda
09

References and documents

Study documents

  • Protocol, analysis plan and consent form · Jan 12, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04718974
Lead sponsor
Makerere University
Collaborators
Infectious Diseases Institute, Uganda
Responsible party
Sponsor
First posted
Jan 22, 2021
Start date
Aug 12, 2020
Primary completion
May 30, 2022
Completion
Jun 30, 2022
Results posted
Feb 21, 2024
Last update
Feb 21, 2024

Study contacts

Agnes B Naggirinya, MMed
principal investigator · Infectious Diseases Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion